Endo issued subpoena regarding Lidoderm promotion

Endo Pharmaceuticals was issued a subpoena by the Department of Health and Human Services regarding the promotion of its post-shingles pain patch Lidoderm, requesting documents from 1999 to the present related to the company's knowledge of off-label uses for the treatment.

You must be a registered member of MMM to post a comment.

Next Article in Pharmaceutical